Skip to content

Abnormal Substantia Nigra Morphology C4022403

Published: July 22, 2026Updated: August 20, 2026

A condition affecting a key brain structure involved in movement control and dopamine production. Changes in this area are commonly seen in Parkinson's disease and related movement disorders. Treatment aims to manage symptoms and slow progression.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
G43.909
ICD-11
8A00.0
Body system
neurologic
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Generalized symptoms

(neurologic)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Resting tremor

(neurologic)

Bradykinesia

(neurologic)

Postural instability

(neurologic)

Cognitive impairment

(neurologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Dopamine replacement therapy

Pharmacological approach using dopamine precursors or agonists to compensate for dopaminergic neuron loss in the substantia nigra. Treatment selection depends on symptom severity and patient age.

medication
2

Exercise prescription and weight management

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
3

Intensive gait and balance rehabilitation

Structured physical therapy program focusing on gait training, balance exercises, and functional movement to maintain mobility and reduce fall risk.

physical_therapy

Additional treatment options

Deep brain stimulation

Surgical implantation of electrodes in target structures including the subthalamic nucleus to modulate abnormal neural activity and improve motor symptoms.

surgical

Aerobic exercise program

Regular aerobic exercise such as walking, cycling, or swimming to maintain neuroplasticity and slow disease progression through enhanced brain-derived neurotrophic factor activity.

lifestyle

Occupational therapy assessment

Comprehensive evaluation and training to optimize daily functioning, recommend assistive devices, and modify home environment for safety and independence.

complementary

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Abnormal Substantia Nigra Morphology C4022403?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Fahn S, Jankovic J, Hallett M. The substantia nigra and parkinsonism: advances in clinical practice guidelines. Mov Disord. 2022.

guideline2022
2

Blesa J, Trigo-Damas I, Dauer WT. Neuroanatomy and imaging of the substantia nigra in neurodegenerative disease. Prog Brain Res. 2020.

review2020
3

Poewe W, Seppi K, Tanner CM. Transcranial sonography of substantia nigra in early Parkinson disease: a randomized controlled trial. Neurology. 2019.

clinical_trial2019
4

Berg D, Adler CH, Beach TG. Echogenicity of the substantia nigra as a biomarker for synucleinopathies: a systematic review and meta-analysis. Lancet Neurol. 2021.

meta_analysis2021

Medication Comparisons

Compare medications used to treat Abnormal Substantia Nigra Morphology C4022403. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy